Trials / Completed
CompletedNCT01190657
Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer
A Multiple-center, Self-controlled Open Study to Evaluate Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1,184 (actual)
- Sponsor
- Eisai Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a self-controlled, open, multiple-center clinical trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Selbex | 50mg/day, 3 times/day, for 14 days |
| DRUG | Selbex | 50mg/day, 3 times/day, for 56 days |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2013-02-01
- Completion
- 2013-02-01
- First posted
- 2010-08-27
- Last updated
- 2013-04-01
Locations
26 sites across 1 country: China
Source: ClinicalTrials.gov record NCT01190657. Inclusion in this directory is not an endorsement.